SOPH
NASDAQ HealthcareSOPHiA GENETICS SA - Ordinary Shares
Health Information Services
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland.
๐ Market Data
| Price | $7.63 |
|---|---|
| Volume | 203,087 |
| Market Cap | 649.53M |
| Beta | 0.920 |
| RSI (14-Day) | 75.0 Overbought |
| 200-Day MA | $5.09 |
| 50-Day MA | $5.88 |
| 52-Week High | $7.88 |
| 52-Week Low | $3.10 |
| Forward P/E | -15.26 |
| Price / Book | 7.82 |
๐ฏ Investment Strategy Scores
SOPH scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (90/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (5/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find SOPH in your text
Paste any article, transcript, or post โ the tool will extract SOPH and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.